PVA42 Antibody

Shipped with Ice Packs
In Stock

Description

Lentiviral Vector Hepatic Gene Delivery and Post-Vector Administration (PVA) Timelines

Research on hepatic lentiviral vector transduction frequently references "PVA" (Post-Vector Administration) timepoints, such as "week 3-PVA," to denote intervals after vector delivery . These studies analyze transgene expression kinetics and host genetic factors influencing therapeutic outcomes. Key findings include:

Table 1: Heritability of Hepatic Transgene Expression Traits

PhenotypeHeritability (%)p-Value
Liver Luciferase Week 144.94<0.0001
Liver Luciferase Week 2445.45<0.0001
Liver VCN/Spleen VCN Ratio54.28<0.0001
  • Host genetic loci (e.g., Sertad4, Irf6, Traf3ip3, UTP25) on chromosome 1 regulate transgene expression changes post-PVA .

  • Strain-specific variability in vector copy number (VCN) and luciferase expression underscores the role of genetic background in gene therapy efficacy .

Anti-PF4 Antibodies and COVID-19

Anti-PF4 antibodies, while unrelated to "PVA42," demonstrate significant clinical relevance in thrombotic disorders and COVID-19:

Table 2: Anti-PF4 Antibody Detection in COVID-19 Patients

StudyAnti-PF4+ Rate (No Heparin)Clinical Correlation
Liu et al.93.1%Disease severity, platelet decline
Ueland et al.7.69%ICU admission, inflammation
  • Anti-PF4 antibodies correlate with disease severity and immune dysregulation .

Monoclonal Antibodies Targeting Amyloid-β42 (Aβ42)

Aβ42 fibril-targeting monoclonal antibodies (e.g., OC-type) highlight structural polymorphisms in amyloid aggregates:

  • 23 OC-type antibodies recognize distinct conformational epitopes on Aβ42 fibrils .

  • Epitope diversity influences therapeutic targeting efficacy in neurodegenerative diseases .

Antibody Engineering and Characterization

Advanced platforms like Genmab’s DuoBody® enable high-throughput screening of bispecific antibodies (bsAbs):

  • Mass spectrometry (MS)-based assays reduce data processing time by 95% compared to traditional CEX chromatography .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PVA42 antibody; At4g21450 antibody; F18E5.70 antibody; Vesicle-associated protein 4-2 antibody; Plant VAP homolog 4-2 antibody; AtPVA42 antibody; VAMP-associated protein 4-2 antibody
Target Names
PVA42
Uniprot No.

Target Background

Function
PVA42 Antibody may play a role in vesicle trafficking.
Database Links

KEGG: ath:AT4G21450

UniGene: At.28664

Protein Families
VAMP-associated protein (VAP) (TC 9.B.17) family

Q&A

What is PVA42 and what functional roles does it play in plants?

PVA42 (AT4G21450) is a protein in Arabidopsis thaliana that may play a significant role in vesicle trafficking . The protein is part of specific cellular pathways identified in the KEGG database (ath:AT4G21450) and has been cataloged in UniGene (At.28664) . Understanding its function requires careful experimental design using specific antibodies against the protein to elucidate its role in plant cellular processes.

What applications has PVA42 Antibody been validated for?

PVA42 Antibody has been validated primarily for ELISA and Western Blot (WB) applications . These applications enable researchers to detect and quantify PVA42 protein expression in plant samples. The antibody is particularly useful for identifying native PVA42 in Arabidopsis thaliana samples, with Western blotting providing information about protein size and relative abundance, while ELISA offers quantitative measurements of protein levels.

What are the key specifications researchers should know about PVA42 Antibody?

The comprehensive specifications for PVA42 Antibody include:

CharacteristicSpecificationReference
HostRabbit
ClonalityPolyclonal
ImmunogenRecombinant Arabidopsis thaliana PVA42 protein
Species ReactivityArabidopsis thaliana (plant)
ApplicationsELISA, Western Blot
Purification MethodProtein A/G
UniProt NumberQ8VYN2
ConjugationNon-conjugated
IsotypeIgG

These specifications are essential for experimental planning and ensuring appropriate use of the antibody in research protocols.

How should validation experiments be designed for PVA42 Antibody?

Antibody validation is critical for ensuring experimental reliability. A comprehensive "fit for purpose" approach should be implemented :

  • Cell-type specificity assessment: Compare signal between positive samples (expressing PVA42) and negative samples (not expressing PVA42).

  • Mixed population experiment: Create defined mixtures of positive and negative cells across a specified dynamic range, then compare known percent composition to experimentally determined percent positivity.

  • Knockout/knockdown validation: Test antibody on samples where PVA42 has been genetically modified or removed.

  • Independent detection method: Confirm antibody findings using orthogonal techniques such as mass spectrometry or RNA-seq.

  • Documentation: Record all validation parameters including antibody dilution, incubation time, blocking conditions, and detection methods.

This systematic approach ensures that the antibody can reliably detect the target protein in your specific experimental context .

What controls should be included in experiments using PVA42 Antibody?

Rigorous controls are essential for antibody-based experiments with PVA42:

  • Primary controls:

    • Positive control: A sample known to express PVA42 (e.g., wild-type Arabidopsis tissue)

    • Negative control: A sample known not to express PVA42 (e.g., PVA42 knockout plant)

    • Pre-immune serum control: To assess non-specific binding (pre-immune serum is available with the antibody)

  • Secondary controls:

    • No primary antibody: To detect non-specific binding of secondary antibody

    • Isotype control: To account for non-specific binding effects

    • Peptide competition: To confirm epitope specificity (pre-incubation with immunizing peptide)

  • Sample processing controls:

    • Loading control: Detection of a constitutively expressed protein

    • Cross-reactivity control: Testing on non-target tissues

These controls help distinguish between specific and non-specific signals, ensuring reliable interpretation of results.

What is the optimal protocol for using PVA42 Antibody in Western blot analysis?

For optimal Western blot performance with PVA42 Antibody:

  • Sample preparation:

    • Extract plant proteins in RIPA buffer (similar to protocols used for other plant antibodies)

    • Include protease inhibitors to prevent degradation

    • Determine protein concentration using Bradford or BCA assay

  • Electrophoresis and transfer:

    • Load 25-35 μg of protein per lane (based on protocols for similar plant proteins)

    • Separate proteins on 10-12% SDS-PAGE gel

    • Transfer to PVDF or nitrocellulose membrane

  • Blocking and antibody incubation:

    • Block with 5% non-fat milk in TBST for 1 hour at room temperature

    • Incubate with PVA42 Antibody at recommended dilution (starting at 1:1000)

    • Incubate overnight at 4°C with gentle agitation

  • Detection:

    • Wash membrane thoroughly with TBST (3-5 times, 5 minutes each)

    • Incubate with appropriate secondary antibody (anti-rabbit IgG)

    • Detect using chemiluminescence, similar to methods used for other plant antibodies

  • Validation:

    • Include peptide competition control with recombinant immunogen protein

    • Include positive and negative tissue controls

This protocol should be optimized for specific experimental conditions, with particular attention to antibody dilution and incubation time.

How can researchers effectively use PVA42 Antibody for immunofluorescence in plant tissues?

For immunofluorescence microscopy using PVA42 Antibody in plant tissues:

  • Tissue preparation:

    • Fix plant tissue in 4% paraformaldehyde

    • Section tissues at appropriate thickness (5-10 μm) using a microtome

    • Mount sections on positively charged slides

  • Antigen retrieval and blocking:

    • Perform antigen retrieval if necessary (citrate buffer, pH 6.0)

    • Block with 2-5% BSA or normal serum in PBS with 0.1% Triton X-100

    • Block for 1-2 hours at room temperature

  • Antibody incubation:

    • Dilute PVA42 Antibody (start with 1:100 to 1:500)

    • Incubate overnight at 4°C in a humidified chamber

    • Wash thoroughly with PBS (3-5 times, 5 minutes each)

  • Detection:

    • Incubate with fluorescently labeled secondary antibody (e.g., Alexa Fluor 488)

    • Include DAPI for nuclear counterstaining

    • Mount with anti-fade mounting medium

  • Controls and validation:

    • Include cell-specific markers for co-localization studies

    • Use pre-immune serum as a negative control

    • Perform peptide competition as specificity control

Cell-specific markers can help identify particular plant cell types and subcellular structures, enhancing the interpretation of PVA42 localization data .

What are common issues with PVA42 Antibody experiments and how can they be resolved?

When working with PVA42 Antibody, researchers may encounter several common challenges:

IssuePossible CausesSolutions
Weak or no signalLow antibody concentration
Insufficient antigen
Protein degradation
Increase antibody concentration
Load more protein
Add protease inhibitors
High backgroundInsufficient blocking
High antibody concentration
Insufficient washing
Increase blocking time/concentration
Dilute antibody further
Increase wash duration/frequency
Non-specific bandsCross-reactivity
Protein degradation
Secondary antibody issues
Perform peptide competition
Use fresher samples
Test different secondary antibody
Inconsistent resultsLot-to-lot variation
Sample preparation differences
Storage conditions
Validate each new lot
Standardize sample preparation
Follow storage recommendations

For optimal results, store PVA42 Antibody at -20°C or -80°C and avoid repeated freeze-thaw cycles to maintain antibody activity .

How can researchers validate antibody specificity for PVA42 given its vesicle trafficking role?

Since PVA42 is involved in vesicle trafficking, validating antibody specificity requires specialized approaches:

  • Subcellular fractionation: Isolate vesicular compartments from plant cells and compare PVA42 distribution across fractions.

  • Co-localization studies: Perform dual immunofluorescence with established markers of vesicle trafficking pathways.

  • Perturbation experiments: Observe changes in PVA42 localization after treatment with trafficking inhibitors (e.g., Brefeldin A).

  • Genetic approaches: Compare antibody staining patterns in wild-type versus mutants with disrupted trafficking pathways.

  • Mass spectrometry validation: Immunoprecipitate with PVA42 Antibody and confirm protein identity via mass spectrometry.

These approaches provide complementary evidence for antibody specificity and help establish the functional context of PVA42 in vesicular transport systems.

How can PVA42 Antibody be used in comparative studies across different plant species?

To conduct cross-species studies using PVA42 Antibody:

  • Sequence analysis: Perform bioinformatic analysis to identify PVA42 homologs in target species and assess sequence conservation.

  • Epitope conservation: Determine if the epitope recognized by the antibody is conserved in the species of interest.

  • Cross-reactivity testing: Perform Western blot analysis on samples from different plant species alongside positive controls.

  • Validation hierarchy:

    • Start with closely related species (higher likelihood of cross-reactivity)

    • Use multiple detection methods for confirmation

    • Consider raising species-specific antibodies for divergent homologs

  • Data interpretation: Account for potential differences in protein size, modification, and expression levels across species.

This methodical approach allows researchers to leverage PVA42 Antibody beyond its validated reactivity with Arabidopsis thaliana, expanding its utility in comparative plant biology studies.

How can researchers integrate PVA42 studies with vesicle trafficking analysis in plants?

To investigate PVA42's role in vesicle trafficking:

  • Marker co-localization: Use dual immunofluorescence with established trafficking markers (e.g., RAB GTPases, SNAREs) to determine PVA42's compartmental association.

  • Live imaging: Combine immunofluorescence data with live-cell imaging using fluorescently tagged trafficking components.

  • Pharmacological approaches: Examine PVA42 distribution after treatment with:

    • Brefeldin A (disrupts ER-Golgi trafficking)

    • Wortmannin (affects endosomal trafficking)

    • Latrunculin B (disrupts actin-dependent trafficking)

  • Genetic interaction studies: Analyze PVA42 localization and function in mutants affecting different trafficking pathways.

  • Cargo tracking assays: Determine if PVA42 affects the movement of known vesicular cargo proteins.

These approaches can provide mechanistic insights into how PVA42 contributes to plant vesicle trafficking processes, leveraging the specificity of the antibody for localization studies.

What considerations are important when analyzing PVA42 in transgenic plant models?

When using PVA42 Antibody in transgenic plant studies:

  • Expression level assessment: Quantify endogenous versus transgenic PVA42 expression levels using calibrated Western blotting.

  • Spatial localization: Compare subcellular localization of native versus modified PVA42 using immunofluorescence techniques.

  • Functional interference: Consider whether epitope tags or fusion proteins might affect antibody recognition or protein function.

  • Controls for transgenic studies:

    • Wild-type control (endogenous PVA42 only)

    • PVA42 knockout/knockdown (negative control)

    • Known expression level controls

  • Time-course analysis: Evaluate expression and localization at different developmental stages to capture dynamic regulation.

Similar to lentiviral vector transduction studies that analyze transgene expression at different time points post-vector administration (PVA), researchers should track PVA42 expression over time in transgenic plant models .

How can PVA42 Antibody be used in proteomic analyses of plant vesicle trafficking?

For integrating PVA42 research with broader proteomic studies:

  • Immunoprecipitation-mass spectrometry (IP-MS):

    • Use PVA42 Antibody for immunoprecipitation of protein complexes

    • Analyze co-precipitated proteins by LC-MS/MS

    • Compare results with and without crosslinking to capture transient interactions

  • Proximity labeling approaches:

    • Combine with BioID or APEX2 proximity labeling

    • Identify proteins within the PVA42 microenvironment

    • Validate key interactions with co-immunoprecipitation using PVA42 Antibody

  • Vesicle isolation and characterization:

    • Isolate vesicle populations based on density and size

    • Use PVA42 Antibody to identify PVA42-positive vesicles

    • Characterize vesicle content through proteomics and lipidomics

  • Quantitative proteomics:

    • Compare vesicle proteome in wild-type versus PVA42-modified plants

    • Use SILAC or TMT labeling for quantitative comparison

    • Identify pathways affected by PVA42 perturbation

These approaches can reveal protein networks and molecular mechanisms associated with PVA42 function in vesicle trafficking.

What strategies can be employed for multiplexed detection of PVA42 with other trafficking proteins?

For simultaneous analysis of multiple proteins including PVA42:

  • Multiplex immunofluorescence:

    • Use primary antibodies from different host species

    • Employ species-specific secondary antibodies with distinct fluorophores

    • Optimize antibody dilutions to minimize cross-reactivity

    • Include appropriate controls for each antibody

  • Sequential immunostaining:

    • Perform sequential rounds of staining with antibody stripping between rounds

    • Start with the lowest abundance target (often PVA42)

    • Document complete removal of antibodies between rounds

  • Mass cytometry (CyTOF) adaptation for plant systems:

    • Label antibodies with distinct metal isotopes

    • Enable highly multiplexed protein detection

    • Optimize sample preparation for plant tissues

  • Proximity ligation assay (PLA):

    • Detect protein-protein interactions in situ

    • Combine PVA42 Antibody with antibodies against potential interacting partners

    • Generate fluorescent signal only when proteins are in close proximity

These techniques allow researchers to study the spatial and temporal relationships between PVA42 and other components of the vesicle trafficking machinery.

How might PVA42 Antibody applications evolve with advances in plant cell biology techniques?

As plant cell biology techniques advance, several emerging applications for PVA42 Antibody can be anticipated:

  • Super-resolution microscopy applications:

    • Implement STORM, PALM, or STED microscopy for nanoscale resolution of PVA42 localization

    • Combine with vesicle markers for detailed structural analysis

    • Develop optimized sample preparation protocols for plant cells

  • Intravital imaging adaptations:

    • Develop methods for antibody-based detection in living plant tissues

    • Combine with minimally invasive sample preparation techniques

    • Track dynamic changes in PVA42 localization

  • Single-cell analysis integration:

    • Adapt PVA42 detection for single-cell proteomics

    • Correlate protein levels with transcriptomic data

    • Identify cell-specific roles of PVA42

  • Cryo-electron microscopy applications:

    • Use immunogold labeling with PVA42 Antibody for ultrastructural localization

    • Determine precise subcellular compartments containing PVA42

    • Correlate with functional studies of vesicle trafficking

These emerging techniques will enable researchers to gain deeper insights into the dynamic spatial and temporal aspects of PVA42 function in plant cells.

What considerations should guide researchers in designing longitudinal studies of PVA42?

For designing robust longitudinal studies of PVA42 using antibody-based detection:

  • Temporal sampling strategy:

    • Define appropriate time points based on developmental stages or stress responses

    • Consider both short-term (minutes to hours) and long-term (days to weeks) dynamics

    • Implement consistent sampling procedures across time points

  • Sample archiving and analysis:

    • Develop protocols for sample preservation that maintain antigen integrity

    • Process samples in batches to minimize technical variation

    • Include reference samples across batches for normalization

  • Quantification approaches:

    • Establish quantitative metrics for PVA42 levels and localization patterns

    • Implement automated image analysis for consistency

    • Use appropriate statistical methods for time-series data

  • Integration with physiological data:

    • Correlate PVA42 dynamics with physiological parameters

    • Document environmental conditions throughout the study

    • Consider parallel analysis of related proteins

Similar to studies of lentiviral vector transduction that track changes over time (e.g., "week 1-PVA" vs. "week 3-PVA") , researchers should establish clear temporal frameworks for analyzing PVA42 dynamics in relation to plant development or responses to environmental stimuli.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.